Paper35950872
Impact of 100 LRRK2 variants linked to Parkinson's disease on kinase activity and microtubule binding.
Kalogeropulou AF and 8 others. Biochem J, 2022. Cited by 113 papers, by iCite.
Cite this record
ConductScience Library. Impact of 100 LRRK2 variants linked to Parkinson's disease on kinase activity and microtubule binding. Papers, record 35950872. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35950872
- Cell line
- HEK293847 papers
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Impact of 100 LRRK2 variants linked to Parkinson's disease on kinase activity and microtubule binding.
- PubMed
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Cell lines1
Source Cell lines
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Parkinson Disease | Major topic |
| Humans | |
| Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 | |
| Microtubules | |
| Mutation | |
| Phosphorylation | |
| Protein Binding |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| MC_UU_12016/2 | Medical Research Council | United Kingdom | PubMed | |
| SCAF/18/01 | Chief Scientist Office | United Kingdom | PubMed | |
| MC_UU_00018/1 | Medical Research Council | United Kingdom | PubMed |
Source PubMed
References64
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31663853 | PPM1H phosphatase counteracts LRRK2 signaling by selectively dephosphorylating Rab proteins. | Elife | 2019 | https://conductscience.org/library/papers/31663853 | PubMed |
| 2 | 33640967 | Identification of LRRK2 missense variants in the accelerating medicines partnership Parkinson's disease cohort. | Hum Mol Genet | 2021 | https://conductscience.org/library/papers/33640967 | PubMed |
| 3 | 34145320 | Understanding LRRK2 kinase activity in preclinical models and human subjects through quantitative analysis of LRRK2 and pT73 Rab10. | Sci Rep | 2021 | https://conductscience.org/library/papers/34145320 | PubMed |
| 4 | 29125462 | Systematic proteomic analysis of LRRK2-mediated Rab GTPase phosphorylation establishes a connection to ciliogenesis. | Elife | 2017 | https://conductscience.org/library/papers/29125462 | PubMed |
| 5 | 29212815 | Rab29 activation of the Parkinson's disease-associated LRRK2 kinase. | EMBO J | 2018 | https://conductscience.org/library/papers/29212815 | PubMed |
| 6 | 20659021 | Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser(910)/Ser(935), disruption of 14-3-3 binding and altered cytoplasmic localization. | Biochem J | 2010 | https://conductscience.org/library/papers/20659021 | PubMed |
| 7 | 29127256 | Development of phospho-specific Rab protein antibodies to monitor in vivo activity of the LRRK2 Parkinson's disease kinase. | Biochem J | 2018 | https://conductscience.org/library/papers/29127256 | PubMed |
| 8 | 30467121 | LRRK2 and Rab GTPases. | Biochem Soc Trans | 2018 | https://conductscience.org/library/papers/30467121 | PubMed |
| 9 | 29177506 | LRRK2 phosphorylates membrane-bound Rabs and is activated by GTP-bound Rab7L1 to promote recruitment to the trans-Golgi network. | Hum Mol Genet | 2018 | https://conductscience.org/library/papers/29177506 | PubMed |
| 10 | 17447891 | LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity. | Biochem J | 2007 | https://conductscience.org/library/papers/17447891 | PubMed |
| 11 | 27166375 | ConSurf 2016: an improved methodology to estimate and visualize evolutionary conservation in macromolecules. | Nucleic Acids Res | 2016 | https://conductscience.org/library/papers/27166375 | PubMed |
| 12 | 31552791 | LRRK2 binds to the Rab32 subfamily in a GTP-dependent manner via its armadillo domain. | Small GTPases | 2021 | https://conductscience.org/library/papers/31552791 | PubMed |
| 13 | 23843252 | dbNSFP v2.0: a database of human non-synonymous SNVs and their functional predictions and annotations. | Hum Mutat | 2013 | https://conductscience.org/library/papers/23843252 | PubMed |
| 14 | 31292254 | The dynamic switch mechanism that leads to activation of LRRK2 is embedded in the DFGψ motif in the kinase domain. | Proc Natl Acad Sci U S A | 2019 | https://conductscience.org/library/papers/31292254 | PubMed |
| 15 | 23967090 | Fine-mapping, gene expression and splicing analysis of the disease associated LRRK2 locus. | PLoS One | 2013 | https://conductscience.org/library/papers/23967090 | PubMed |
| 16 | 30635421 | Crystal structure of the WD40 domain dimer of LRRK2. | Proc Natl Acad Sci U S A | 2019 | https://conductscience.org/library/papers/30635421 | PubMed |
| 17 | 23924436 | Differential effects of familial parkinson mutations in LRRK2 revealed by a systematic analysis of autophosphorylation. | Biochemistry | 2013 | https://conductscience.org/library/papers/23924436 | PubMed |
| 18 | 20629711 | Confirmation of LRRK2 S1647T variant as a risk factor for Parkinson's disease in southern China. | Eur J Neurol | 2011 | https://conductscience.org/library/papers/20629711 | PubMed |
| 19 | 22080837 | LRRK2 Parkinson disease mutations enhance its microtubule association. | Hum Mol Genet | 2012 | https://conductscience.org/library/papers/22080837 | PubMed |
| 20 | 34515301 | Impact of Type II LRRK2 inhibitors on signaling and mitophagy. | Biochem J | 2021 | https://conductscience.org/library/papers/34515301 | PubMed |
Cited by95
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 113 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42962668 | Metabolic endotyping for mechanism-informed Alzheimer's and Parkinson's disease trials. | Med | 2026 | https://conductscience.org/library/papers/42962668 | PubMed |
| 42837290 | Parkinson's disease-associated LRRK2 risk variant, G2385R, enhances Rab substrate phosphorylation and impairs neuronal integrity. | Hum Mol Genet | 2026 | https://conductscience.org/library/papers/42837290 | PubMed |
| 42818643 | Chemical Genetic Targeting of the LRRK2 GTPase Domain. | bioRxiv | 2026 | https://conductscience.org/library/papers/42818643 | PubMed |
| 42737506 | LRRK2: Molecular Mechanisms in Parkinson's Disease. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42737506 | PubMed |
| 42601490 | Regulation and roles of mammalian mitophagy. | Nat Rev Mol Cell Biol | 2026 | https://conductscience.org/library/papers/42601490 | PubMed |
| 42575089 | The structural basis for LRRK2's activation and autoinhibition. | Cell | 2026 | https://conductscience.org/library/papers/42575089 | PubMed |
| 42574603 | Selective loss of primary cilia and neurotrophic signaling in G51D α-synuclein mice highlights a common pathway to Parkinson's disease. | Proc Natl Acad Sci U S A | 2026 | https://conductscience.org/library/papers/42574603 | PubMed |
| 42456684 | Parkinson's disease genetics across diverse ancestries: an observational genetic study of causal and risk variants with translational implications. | Lancet Neurol | 2026 | https://conductscience.org/library/papers/42456684 | PubMed |
| 42428074 | LRRK2 in Focus: A Global Browser Linking Genetic Diversity to Functional Effects. | medRxiv | 2026 | https://conductscience.org/library/papers/42428074 | PubMed |
| 42409815 | Whole-genome sequencing of 197 cases with Parkinson's disease reveals novel pathogenic variants in the Indian population. | NPJ Parkinsons Dis | 2026 | https://conductscience.org/library/papers/42409815 | PubMed |
| 42396337 | Large-scale functional annotation establishes a reference framework for human LRRK2 variants. | medRxiv | 2026 | https://conductscience.org/library/papers/42396337 | PubMed |
| 42358068 | Addressing the Challenges of Translating LRRK2 Biology into Disease-Modifying Therapies: The LRRK2 Investigative Therapeutics Exchange Initiative. | Mov Disord | 2026 | https://conductscience.org/library/papers/42358068 | PubMed |
| 42282830 | The structural basis for LRRK2's activation and autoinhibition. | bioRxiv | 2026 | https://conductscience.org/library/papers/42282830 | PubMed |
| 42233523 | Leucine-rich repeat kinase 2 (LRRK2): balancing cellular homeostasis and Parkinson's disease (PD) pathogenesis. | Ann Med | 2026 | https://conductscience.org/library/papers/42233523 | PubMed |
| 42215790 | The C9orf72/SMCR8 complex maintains microglial homeostasis via RAB8A-ESCRT-mediated lysosomal repair. | EMBO J | 2026 | https://conductscience.org/library/papers/42215790 | PubMed |
| 42177293 | Proximity proteomics reveals a co-evolved LRRK2-regulatory network linked to centrosomes. | EMBO Rep | 2026 | https://conductscience.org/library/papers/42177293 | PubMed |
| 42146388 | Elucidating the molecular interplay between LRRK2 and Rab GTPases. | bioRxiv | 2026 | https://conductscience.org/library/papers/42146388 | PubMed |
| 42143840 | Constrained peptide mimics of the LRRK2 C-terminal Helix inhibits its kinase activity. | Bioorg Chem | 2026 | https://conductscience.org/library/papers/42143840 | PubMed |
| 42003785 | Ex Vivo LRRK2 Activation in Asian G2385R and R1628P Variant Carriers and Idiopathic Parkinson's Disease. | Mov Disord | 2026 | https://conductscience.org/library/papers/42003785 | PubMed |
| 41919497 | Genetic analysis of neurodegenerative diseases. | J Clin Invest | 2026 | https://conductscience.org/library/papers/41919497 | PubMed |
Genes13
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35950872
GET https://conductscience.org/api/papers/v1/35950872/references?page=2